Centaurus Financial’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $106K | Buy |
202
+8
| +4% | +$4.2K | 0.01% | 928 |
|
|
2025
Q1 | $123K | Sell |
194
-2
| -1% | -$1.27K | 0.01% | 830 |
|
|
2024
Q4 | $140K | Buy |
196
+76
| +63% | +$54.3K | 0.01% | 777 |
|
|
2024
Q3 | $126K | Buy |
120
+8
| +7% | +$8.4K | 0.01% | 776 |
|
|
2024
Q2 | $118K | Buy |
+112
| New | +$118K | 0.01% | 743 |
|
|
2024
Q1 | – | Sell |
-117
| Closed | -$103K | – | 844 |
|
|
2023
Q4 | $103K | Sell |
117
-48
| -29% | -$42.3K | 0.01% | 751 |
|
|
2023
Q3 | $136K | Buy |
+165
| New | +$136K | 0.01% | 658 |
|
|
2022
Q4 | – | Sell |
-2,112
| Closed | -$1.46M | – | 900 |
|
|
2022
Q3 | $1.46M | Buy |
2,112
+5
| +0.2% | +$3.45K | 0.14% | 176 |
|
|
2022
Q2 | $1.25M | Buy |
2,107
+1
| +0% | +$591 | 0.12% | 201 |
|
|
2022
Q1 | $1.47M | Buy |
2,106
+22
| +1% | +$15.4K | 0.12% | 213 |
|
|
2021
Q4 | $1.32M | Buy |
2,084
+684
| +49% | +$432K | 0.1% | 227 |
|
|
2021
Q3 | $847K | Buy |
1,400
+16
| +1% | +$9.68K | 0.07% | 301 |
|
|
2021
Q2 | $773K | Buy |
+1,384
| New | +$773K | 0.07% | 328 |
|
|
2019
Q2 | – | Sell |
-230
| Closed | -$559 | – | 628 |
|
|
2019
Q1 | $559 | Buy |
+230
| New | +$559 | ﹤0.01% | 546 |
|